Dr. Medhat Raouf, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 60 Skyline Dr, Ringwood, NJ 07456 Phone: 973-962-4000 Fax: 973-962-0640 |
Dr. Mark Rametta, D.O. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 52 Skyline Dr, Ringwood, NJ 07456 Phone: 973-962-6200 Fax: 973-962-0046 |
Mr. Anil Kapoor, MD Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 60 Skyline Drive, Ringwood, NJ 07456 Phone: 973-962-6661 Fax: 973-962-1958 |
Jeannette Carol Davison, APNC Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 52 Skyline Dr, Ringwood, NJ 07456 Phone: 973-962-6200 |
News Archive
While obesity significantly increases your chances of developing heart failure, for those with established heart failure it may confer a survival benefit compared with normal weight or underweight individuals, a new paper by researchers from the University of Adelaide reports.
PEPFAR will purchase up to 150 rapid tuberculosis (TB) Xpert testing devices and cartridges to test about 450,000 people for TB, "addressing a need to improve diagnoses of drug-resistant strains of disease, and to identify the disease in HIV-positive people in sub-Saharan Africa and Myanmar, the Office of the Global AIDS Coordinator announced" Tuesday, the Center for Global Health Policy's "Science Speaks" blog reports.
A study from the University of Gothenburg, Sweden, which monitored a group of women for 25 years showed that the combined oral contraceptive pill (the pill) is the most common form of contraceptive among women under 29. At the same time many young women have unwanted pregnancies resulting in repeated abortions. According to the researchers increased use of an intrauterine device at a younger age would reduce the number of unwanted pregnancies.
By cloaking nanoparticles in the membranes of white blood cells, scientists at The Methodist Hospital Research Institute may have found a way to prevent the body from recognizing and destroying them before they deliver their drug payloads. The group describes its "LeukoLike Vectors", or LLVs, in the January issue of Nature Nanotechnology.
› Verified 2 days ago